Skip to main content

Choose your location

Current selection

Australia
English
Canada
United States
Asia Regional
Australia
New Zealand
Austria
Belgium
Denmark
Estonia
Finland
France
Germany
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Netherlands
Norway
Portugal
Spain
Sweden
Switzerland
United Kingdom

Download

Audience for the document: Share Class: Language of the document:

Download

Share Class: Language of the document:

Change Details

If you need to change your email address please contact us.
Subscriptions
OK
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price ("TRP") claims compliance with the Global Investment Performance Standards (GIPS®) and has prepared and presented this report in compliance with the GIPS standards. T. Rowe Price has been independently verified for the twenty four-year period ended June 30, 2020, by KPMG LLP. The verification report is available upon request. A firm that claims compliance with the GIPS standards must establish policies and procedures for complying with all the applicable requirements of the GIPS standards. Verification provides assurance on whether the firm’s policies and procedures related to composite and pooled fund maintenance, as well as the calculation, presentation, and distribution of performance, have been designed in compliance with the GIPS standards and have been implemented on a firm-wide basis. Verification does not provide assurance on the accuracy of any specific performance report.

TRP is a U.S. investment management firm with various investment advisers registered with the U.S. Securities and Exchange Commission, the U.K. Financial Conduct Authority, and other regulatory bodies in various countries and holds itself out as such to potential clients for GIPS purposes. TRP further defines itself under GIPS as a discretionary investment manager providing services primarily to institutional clients with regard to various mandates, which include U.S, international, and global strategies but excluding the services of the Private Asset Management group.

A complete list and description of all of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest

March 2022 / INVESTMENT INSIGHTS

The Great Unwind?

From The Desk February 2022

Our summer holiday unwind is now well and truly behind us with our local reporting season in full swing. However, the other great unwinds that have captured investors’ attention recently are the withdrawals of extraordinary stimulus measures and the global unravelling of growth stocks. The extent that this unwind will continue has been a contentious topic, like many others so far this year (Russia-Ukraine tensions… for example).

Excess policy measures bred some valuation excesses. The gap between the top 20% of PEs and the next 20% rose to levels not seen since the Tech Bubble (Chart 1). With the handbrake being squeezed on excess stimulus, it is not surprising to see excess valuations correct. These areas of excess will likely be those that take the longest to recover, just as they did during the Tech Wreck. As Warren Buffet once said, it is only when the tide goes out that you discover who has been swimming naked.

At the same time, the falling tide of excess stimulus has also hurt a lot of the more modest growth names (or what some refer to as “Growth At A Reasonable Price (GARP)”) that to us still represent quality businesses. In turn, the recent sell-off has also presented good opportunities to take advantage of, rather than de-risk and reduce exposure entirely. During periods where value has outperformed, these GARP names have beaten their more expensive counterparts (Chart 2).

Looking ahead, we believe the unwind of monetary and fiscal policy excesses will continue. We have written in the past about the real risk of a policy error by the Fed if it hikes too aggressively into a downturn. Most leading indicators already point to an economic downturn both here and in the US. In effect, significant stimulus recreated the traditional boom-bust economic cycle. We have witnessed the boom, next it will be followed by the bust. We want to be underweight value and overweight growth when this happens.

Longer-dated yields also suggest rates will not rise significantly in this cycle. Shorter-term rates have already risen and central banks are now simply following market expectations with many, particularly the Fed, well-behind the curve on fighting inflation. Such an environment has typically been positive for growth, which makes sense, as when investors are concerned that the broader economic landscape is weak, they will seek out names that can deliver the growth needed for their portfolios.

Overall, in an era of excesses being unwound and some mean reversion, we prefer not to be too far out the risk spectrum. We believe that by spreading our risk between areas of attractive growth and quality names, based on fundamentals, we can potentially deliver the most consistent outcome for our clients. Similarly, we hope that any excesses accumulated from indulging over the holiday period will also mean-revert.

 

IMPORTANT INFORMATION

This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. It is not intended for distribution to retail investors in any jurisdiction.

Australia - Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 50, Governor Phillip Tower, 1 Farrer Place, Suite 50B, Sydney, NSW 2000, Australia. For Wholesale Clients only.

New Zealand - Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 50, Governor Phillip Tower, 1 Farrer Place, Suite 50B, Sydney, NSW 2000, Australia. No Interests are offered to the public. Accordingly, the Interests may not, directly or indirectly, be offered, sold or delivered in New Zealand, nor may any offering document or advertisement in relation to any offer of the Interests be distributed in New Zealand, other than in circumstances where there is no contravention of the Financial Markets Conduct Act 2013.

Previous Article

March 2022 / VIDEO

Russia-Ukraine Crisis – Investment Implications
Next Article

March 2022 / EMERGING MARKETS

A Q&A Session With Ernest Yeung
202202-2052447

December 2021 / INTERNATIONAL EQUITIES

Aussie Banks: Tougher Times Ahead

Aussie Banks: Tougher Times Ahead

Aussie Banks: Tougher Times Ahead

By Nicholas Vidale

Nicholas Vidale Financials Investment Analyst

You are now leaving the T. Rowe Price website

T. Rowe Price is not responsible for the content of third party websites, including any performance data contained within them. Past performance cannot guarantee future results.